These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 24911039

  • 21. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 22. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 23. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
    Castro A, Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    HLA; 2017 Nov; 90(5):267-275. PubMed ID: 28776960
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Natural history of proteinuria in renal transplant recipients developing de novo human leukocyte antigen antibodies.
    Fotheringham J, Angel C, Goodwin J, Harmer AW, McKane WS.
    Transplantation; 2011 May 15; 91(9):991-6. PubMed ID: 21519315
    [Abstract] [Full Text] [Related]

  • 28. Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients.
    Comoli P, Cioni M, Tagliamacco A, Quartuccio G, Innocente A, Fontana I, Trivelli A, Magnasco A, Nocco A, Klersy C, Rubert L, Ramondetta M, Zecca M, Garibotto G, Ghiggeri GM, Cardillo M, Nocera A, Ginevri F.
    Am J Transplant; 2016 Jul 15; 16(7):2106-16. PubMed ID: 26725780
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort.
    Charnaya O, Tuchman S, Moudgil A.
    Pediatr Transplant; 2018 Mar 15; 22(2):. PubMed ID: 29356221
    [Abstract] [Full Text] [Related]

  • 32. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.
    Transpl Immunol; 2013 Dec 15; 29(1-4):28-33. PubMed ID: 23907088
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. De novo donor-specific HLA antibodies in heart transplantation: Do transient de novo DSA confer the same risk as persistent de novo DSA?
    Moayedi Y, Fan CS, Tinckam KJ, Ross HJ, McCaughan JA.
    Clin Transplant; 2018 Nov 15; 32(11):e13416. PubMed ID: 30276870
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Donor specific antibodies before and after kidney transplant: the University of Colorado Experience.
    Cooper JE, Gralla J, Adebiyi O, Wiseman AC, Chan L.
    Clin Transpl; 2013 Nov 15; ():407-12. PubMed ID: 25095536
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.